UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000020315 |
|---|---|
| Receipt number | R000023019 |
| Scientific Title | A pahse 2 study of bortezomib monotherapy for Epstein-Barr virus positive T or NK cell lymphoproliferative disease (Chronic active Epstein-Barr virus infection) |
| Date of disclosure of the study information | 2015/12/24 |
| Last modified on | 2019/12/25 09:32:21 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/12/22 21:06:27 | ||
| 2 | Update | 2016/12/22 09:27:45 | Name of primary person or sponsor Organization |
|
| 3 | Update | 2019/04/05 09:15:33 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 4 | Update | 2019/12/25 09:32:21 | Number of participants that the trial has enrolled Results Results Delayed Results Delay Reason Results Delay Reason Baseline Characteristics Participant flow Adverse events Outcome measures |
